Evolutec Annual Report and Accounts
27/02/2007
Evolutec Group plc (AIM: EVC), the biopharmaceutical company developing novel
products for the treatment of allergic, inflammatory, and autoimmune diseases,
announces results for the year ended 31 December 2006.